Russell Investments Group, Ltd. Relay Therapeutics, Inc. Transaction History
Russell Investments Group, Ltd.
- $60.3 Billion
- Q2 2024
A detailed history of Russell Investments Group, Ltd. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 19,427 shares of RLAY stock, worth $127,052. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,427
Previous 179,972
89.21%
Holding current value
$127,052
Previous $1.49 Million
91.56%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RLAY
# of Institutions
183Shares Held
127MCall Options Held
1.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$182 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$76.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$68.9 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.45MShares$55.3 Million4.77% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$41.7 Million0.7% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $786M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...